Clinical Trial Update: A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated brexpiprazole versus placebo for acute manic episodes in Bipolar I Disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Manic Episode

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder, Manic Episode | Phase 3 | Status: COMPLETED | Results posted: 2020-02-10